Low coverage of HPV vaccination in the national immunization programme in Brazil: Parental vaccine refusal or barriers in health-service based vaccine delivery?
William Mendes Lobão, Fernanda Gross Duarte, Jordan Danielle Burns, Carlos Antonio de Souza Teles Santos, Maria Conceição Chagas de Almeida, Arthur Reingold, Edson Duarte Moreira
Author Information
William Mendes Lobão: Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Fernanda Gross Duarte: School of Public Health, Berkeley, CA, United States of America. ORCID
Jordan Danielle Burns: Rollins School of Public Health, Emory University, GA, United States of America.
Carlos Antonio de Souza Teles Santos: Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Maria Conceição Chagas de Almeida: Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Brazil.
Arthur Reingold: School of Public Health, Berkeley, CA, United States of America.
BACKGROUND: The World Health Organization has recommended the introduction of HPV vaccines into national immunization programme (NIP), but vaccination coverage remains low worldwide. We assessed the coverage and the parental acceptance of female and male HPV vaccination in Brazil after its introduction into the NIP. METHODS: We conducted a random-digit-dial survey of parents in seven major Brazilian cities from July-2015 to October-2016. A knowledge, attitude and practices questionnaire was developed and validated by expert analysis, semantic analysis, and pre-testing. RESULTS: 826 out of 2,324 (35.5%) eligible parents completed the interview. Parental acceptance of the HPV vaccine for daughters and sons 18 years of age or less was high (92% and 86%, respectively). Parents refusing vaccination were less likely to know that: HPV is sexually transmitted and causes genital warts, HPV vaccination is more beneficial before sexual debut, and HPV vaccine reactions are minor, and they were more likely to believe HPV vaccination can cause severe adverse events. Parents accepting HPV vaccine for daughters but not forsons were more likely to ignore that the vaccine is recommended for boys. Attitudes associated with HPV vaccine acceptance included: general belief in vaccines, trust in the NIP and in the HPV vaccine efficacy. Among girls eligible for HPV vaccination through the NIP, 58.4% had received a two-dose scheme and 71.1% at least one dose. "No vaccination/missed vaccination at school" was the most common reason for missed HPV vaccination in theNIP. CONCLUSIONS: One year after introduction in the NIP, most parents surveyed in Brazil accepted HPV vaccination for their daughters and sons. Low coverage in the NIP seemed to be due to challenges in adolescent vaccine delivery and HPV vaccination barriers at health-care centers, rather than to vaccine refusal.
